Giant cell arteritis and rheumatic polymyalgia require hormone therapy under the supervision of a physician, and in the former case, a combination of aspirin and other treatments. Giant cell arteritis is a subacute rheumatic disease characterized by atypical fever, malaise, headache, difficulty opening the mouth, and large vessel disease. The treatment of giant cell arteritis generally requires a full dose of hormones at the start, i.e., prednisone 1 mg/(kg-d), approximately 10 or more tablets per day, in combination with low-dose aspirin therapy. If the disease progresses rapidly and involves the blood vessels of the eye, high-dose hormonal shock therapy, usually 500 mg to 1,000 mg/d, is needed, also in combination with aspirin. Rheumatic polymyalgia is an acute rheumatic disease characterized by pain in the skeletal muscles of the shoulder and neck, pelvic girdle, and trunk, and both are treated with hormone-based therapy. Rheumatic polymyalgia, on the other hand, requires only small doses of hormones, about 2 to 5 tablets of hormones to achieve pain relief. Both diseases require hormonal drug treatment, the use of drugs need to be under the guidance of a physician, do not use on their own.